Merck & Co. Inc. suffered a setback in its Vioxx defence strategy as a Quebec court denied a company request to hear individual lawsuits from patients and instead granted plaintiffs class-action status.
FDA errs on side of caution in drug approvals
TRENTON, N.J. - Under growing scrutiny since the blockbuster painkiller Vioxx was pulled from the market, the Food and Drug Administration (FDA) in recent months has rejected a slew of experimental drugs or delayed their approval and required more data. Besides keeping drugs some patients might desperately need off the market, the rejections have battered drug company stock prices and are... more...
Casino Workers to Decide Next Vioxx Case
In this casino town, it'll be casino workers who help decide whether drug manufacturer Merck & Co. is to blame for heart attacks suffered by two New Jersey men who were taking Vioxx.
